#AIEye
Episode 410: Workday (NasdaqGS: $WDAY) and IBM (NYSE: $IBM) Expand Partnership
for Return to Work Solution, Express Inc. (NYSE: $EXPR) Implements #AI-based S5
Assortment
Global
AI in Drug Discovery Market to See CAGR of 43.24% from 2020-2026
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2020/081320-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2020/artificial-intelligence/08131AIEye-WDAY-IBM.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NasdaqGS:WDAY) (NYSE:IBM) (NYSE:EXPR)
Workday, Inc. (NasdaqGS:WDAY) and IBM (NYSE:IBM) announced “an expanded partnership and the
availability of a joint solution to help business and community leaders plan,
schedule, and monitor a safe return to the workplace for employees.” The two
firms’ integrated solution includes Watson Works, described in the press
release as “a set of products that embeds Watson artificial intelligence (AI)
models and applications to help companies as they navigate many aspects of the
return to workplace challenge, including deciding when to return to the
workplace, connecting employer data to entry privileges, and managing
facilities and adhering to new protocols.” Kareem Yusuf, general manager, AI
Applications, IBM Cloud and Cognitive Software, said:
"Keeping
employees safe during the return to workplace process is of critical importance
to business leaders across industries. By partnering with Workday on a joint
solution, we're extending the capabilities delivered by Watson Works to help
customers gain greater agility to respond to ever-changing working conditions
and evolving business needs. Together we are helping organizations overcome the
complexities involved in continuous planning to ultimately improve workplace
readiness."
Apparel retailer Express, Inc. (NYSE:EXPR)
has partnered with cloud-based AI products company
S5 Stratos Inc., and completed the implementation of S5 Assortment, described
as “a retail assortment planning application that uses AI and machine learning
to track changing consumer demand and predict selling patterns at a
hyper-localized level.” Chetan Anand Gabri, CEO and Co-Founder, S5 Stratos,
explained:
"A
large part of effectively servicing today’s consumer lies in understanding
data. As retailers face unprecedented challenges in gaining and holding market
share, they need solutions that can quickly read and interpret data, and
present relevant insights and recommended actions. S5’s solutions effectively
put the power of advanced data science directly into the hands of the end-user,
empowering better decisions and greater adaptability, which ultimately forges
more agile organizations. By using S5’s AI-driven platform, Express is blazing
the trail for modern retail and pioneering a new era of consumer-centric strategies
in retail."
Global
AI in Drug Discovery Market to See CAGR of 43.24% from 2020-2026
A report published by Research and Markets finds that the global AI
in Drug Discovery market, which was valued at $343.78 million in 2020, will
exhibit a compound annual growth rate (CAGR) of 43.24 percent in the forecast
period 2020-2026. An excerpt from the report’s description reads:
There
is a significant increase in the number of applications that focuses on the
target and drug discovery, preclinical and clinical development, and
post-approval activities. AI can help in improving drug approval rates, reduce
development costs, the swift availability of medications and help patients
comply with their treatments. The global AI in the drug discovery market has a
high demand due to its increasing need to shorten the drug discovery process in
order to get drugs faster for treating various incurable and viral diseases.
Moreover, AI plays an important role to understand the mechanism of disease by
determining biomarkers and creating data or models for the drug discovery
process which will ultimately drive the market over the next few years.
Sam Mowers, Investorideas.com
Read
and hear other editions of the AI Eye
For
a list of artificial intelligence stocks on Investorideas.com visit
here
or become an Investor Ideas member
About Investorideas.com - News that
Inspires Big Investing Ideas Investorideas.com is a
recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
The
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com,
iHeartRadio and Google Play Music.
Visit
the Podcast page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third
party sourced news, articles and equity research as well as creates original
content, including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more
about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock
news, deal tracker and advancements in artificial intelligence is an
original content brand of Investorideas.com
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile
App
for iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800
665 0411
Get more Technology
stock investor ideas - news, articles,
podcasts and stock directories
